Skip to main content
Equibles
ALXO logo

ALXO · Alx Oncology Holdings Inc · Metrics

Track ALXO — free

Use ALXO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ALXO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.94 +0.04 (+2.11%) At close · Sep 11
Russell 2000 member Rebalance outlook locked
Market Cap
$268.26M
Shares
138.28M

ALXO metrics

59 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$1.94
Market cap
$268.26M

Price action

20 metrics
Price change (1W)
-3.5%
Price change (30D)
-1.0%
Price change (3M)
+22.8%
Price change (6M)
-2.0%
Price change (YTD)
+71.7%
Price change (1Y)
+64.4%
Trailing year
Price change (5Y)
-97.5%
52-week high
$2.60
52-week low
$1.05
Change from 52-week high
-25.4%
Change from 52-week low
+84.8%
Annualized volatility
96.0%
Annualized volatility (3M)
76.5%
Beta
1.1
RSI (14D)
47.2
Price vs SMA 50
-4.0%
Price vs SMA 200
+5.9%
Avg volume (3M)
1.28M
Relative volume
0.8
Average dollar volume
$2.50M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
138.28M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
2.0
reciprocal yield 50.8%
FCF yield
-26.4%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-30.2%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-05-08

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
−$82.55M
Net income (TTM)
−$80.89M
Trailing 12 months
Diluted EPS (TTM)
$-1.13
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$0.48

Growth

11 metrics
Revenue growth YoY
-59.3%
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+153.8%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-59.4%
Return on assets
-50.3%
Debt / equity
0.1
Current ratio
9.7
EBITDA (TTM)
−$82.01M
Free cash flow (TTM)
−$70.95M
Quick ratio
9.7
Interest coverage
-58.7
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$128.52M
Latest balance sheet
Cash & equivalents
$22.69M
Total assets
$160.82M
Total debt
$9.71M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$70.78M
Capital expenditures (TTM)
$172,000
R&D (TTM)
$61.83M
SG&A (TTM)
—
Stock compensation (TTM)
$10.42M
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

3 metrics
13F filers
94
13F filer change QoQ
+24
Institutional ownership
76.1%

Short interest

3 metrics
Short interest
5.1%
Latest settlement · 12.3 days to cover
Days to cover
12.3d
Short-squeeze score
70 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$8,274
Insider-sentiment score
49 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1810182 CUSIP 00166B105 13F (30d) 42 filings 42 filers Visit website Investor relations